Related Experiment Video
Updated: Jan 19, 2026

Intravitreous Injection for Establishing Ocular Diseases Model
Published on: October 1, 2007
Recurrence of SRF Post Intravitreal Ranibizumab for Pediatric Choroidal Neovascularisation Secondary to Best Disease
Deivanai Subbiah1, Hanizasurana Hashim1, Fiona Lee Min Chew1
1Department of Ophthalmology, Hospital Selayang , Batu Caves, Selangor, Malaysia.
Abstract:
We present five cases of choroidal neovascularization secondary to pediatric Best disease which were treated with two different doses of intravitreal ranibizumab. Optical coherence tomography was used for monitoring of the cases. Three cases had subretinal fibrosis at presentation and two out of these 3 cases required repeat intravitreal ranibizumab at one year follow-up due to recurrence of subfoveal subretinal fluid.
Related Concept Videos
05:37Intravitreous Injection for Establishing Ocular Diseases Model
03:37Intravitreal Injections in the Ovine Eye
03:59Surgical Correction for Pediatric Epiblepharon and Trichiasis
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
09:56In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model
06:10An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

